Vincogen Corporation

The VincoAI, an AI without filter module, is the first Proof-of-Concept (POC) AI, precisely predicts peptide-protein amino acid sequences based on high-quality data. Unlike the Sequential Model Ensemble Pipeline (SMEP), this moonshot project VincoAI develops revolutionary LSTM and Transformer models, to identify peptide-protein candidates in silico. The utility of VincoAI extends beyond antimicrobial resistance (AMR). It can also be utilized in various areas of Biologics research including pathogen and host protein-protein interaction, stem cells, human phageome analysis, peptide drugs, nanobody and T-cell vaccine R&D. VincoAI has the potential to save the time, money, and resources needed for the discovery of PreClinical Candidates (PCC).